AstraZeneca Pharma India Limited (ASTRAZEN.BO)
INR 6485.35
(0.07%)
INR 6485.35
(0.07%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 64.60 INR | 62.64% |
| 2022 | 39.72 INR | 61.2% |
| 2021 | 24.64 INR | -33.98% |
| 2020 | 37.32 INR | 29.22% |
| 2019 | 28.88 INR | 32.6% |
| 2018 | 21.78 INR | 110.23% |
| 2017 | 10.36 INR | 29.5% |
| 2016 | 8.00 INR | 280.95% |
| 2015 | 2.10 INR | 125.18% |
| 2014 | -8.34 INR | -4070.0% |
| 2013 | -0.20 INR | 99.44% |
| 2012 | -35.81 INR | -552.72% |
| 2011 | 7.91 INR | -69.16% |
| 2010 | 25.65 INR | 11.28% |
| 2009 | 23.05 INR | -21.94% |
| 2008 | 29.53 INR | 20.14% |
| 2007 | 24.58 INR | 26.12% |
| 2006 | 19.49 INR | 13.18% |
| 2005 | 17.22 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -4.72 INR | -129.89% |
| 2023 Q2 | 20.95 INR | -2.74% |
| 2023 Q1 | 21.54 INR | 0.0% |
| 2023 Q4 | 15.79 INR | 149.84% |
| 2023 Q3 | 6.32 INR | -69.83% |
| 2023 FY | - INR | 62.64% |
| 2022 Q3 | 11.72 INR | -10.05% |
| 2022 Q4 | - INR | -100.0% |
| 2022 Q1 | 8.06 INR | -28.04% |
| 2022 Q2 | 13.03 INR | 61.66% |
| 2022 FY | - INR | 61.2% |
| 2021 Q3 | 4.57 INR | -4.39% |
| 2021 Q4 | 11.20 INR | 145.08% |
| 2021 FY | - INR | -33.98% |
| 2021 Q1 | 4.10 INR | -62.42% |
| 2021 Q2 | 4.78 INR | 16.59% |
| 2020 Q2 | 10.64 INR | 42.82% |
| 2020 FY | - INR | 29.22% |
| 2020 Q4 | 10.91 INR | 29.57% |
| 2020 Q3 | 8.42 INR | -20.86% |
| 2020 Q1 | 7.45 INR | 0.0% |
| 2019 Q1 | 8.61 INR | 0.0% |
| 2019 Q2 | 5.77 INR | -32.98% |
| 2019 Q3 | 10.68 INR | 85.1% |
| 2019 Q4 | - INR | -100.0% |
| 2019 FY | - INR | 32.6% |
| 2018 FY | - INR | 110.23% |
| 2018 Q3 | 11.64 INR | 218.9% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q1 | 2.58 INR | 100.0% |
| 2018 Q2 | 3.65 INR | 41.47% |
| 2017 Q4 | 1.29 INR | 131.16% |
| 2017 Q3 | -4.14 INR | -137.81% |
| 2017 Q2 | 10.95 INR | 371.98% |
| 2017 Q1 | 2.32 INR | 160.73% |
| 2017 FY | - INR | 29.5% |
| 2016 Q2 | 0.32 INR | -93.65% |
| 2016 Q4 | -3.82 INR | -158.95% |
| 2016 Q3 | 6.48 INR | 1925.0% |
| 2016 FY | - INR | 280.95% |
| 2016 Q1 | 5.04 INR | 0.0% |
| 2015 FY | - INR | 125.18% |
| 2015 Q4 | - INR | -100.0% |
| 2015 Q3 | 3.47 INR | 229.48% |
| 2015 Q2 | -2.68 INR | -345.87% |
| 2015 Q1 | 1.09 INR | 0.0% |
| 2014 Q4 | - INR | 100.0% |
| 2014 FY | - INR | -4070.0% |
| 2014 Q1 | -7.04 INR | 0.0% |
| 2014 Q2 | -11.18 INR | -58.81% |
| 2014 Q3 | -5.36 INR | 52.06% |
| 2013 Q4 | - INR | -100.0% |
| 2013 FY | - INR | 99.44% |
| 2013 Q1 | 0.71 INR | 0.0% |
| 2013 Q2 | -0.49 INR | -169.01% |
| 2013 Q3 | 0.61 INR | 224.49% |
| 2012 Q3 | -7.08 INR | 60.78% |
| 2012 Q2 | -18.05 INR | -453.68% |
| 2012 Q1 | -3.26 INR | 0.0% |
| 2012 FY | - INR | -552.72% |
| 2012 Q4 | - INR | 100.0% |
| 2011 Q4 | - INR | -100.0% |
| 2011 Q3 | 5.97 INR | 0.0% |
| 2011 FY | - INR | -69.16% |
| 2010 FY | - INR | 11.28% |
| 2009 FY | - INR | -21.94% |
| 2008 FY | - INR | 20.14% |
| 2007 FY | - INR | 26.12% |
| 2006 FY | - INR | 13.18% |
| 2005 FY | - INR | 0.0% |